Loose-coupled mitochondria in chronic glucagon-treated hyperthermic ducklings.
In chronic glucagon-treated ducklings (GT) showing thermogenic and hyperthermic responses without shivering to glucagon test injection and in control ducklings (TN; both aged 44 +/- 1 days and reared at thermoneutrality), subsarcolemmal (S) and intermyofibrillar (I) mitochondria from gastrocnemius muscle and mitochondria from liver were isolated. Respiration and cytochrome oxidase activity were determined in these isolated mitochondria by polarography and creatine kinase activity by spectrophotometry, both at 25 degrees C. In GT ducklings, the powerful thermogenesis observed in vivo after a glucagon test injection may be due to the uncoupling effect of released free fatty acids (FFA) in loose-coupled mitochondria because their respiration increased as a function of FFA concentration, and the loose coupling of these mitochondria was reversed by addition of albumin. In all types of mitochondria from GT ducklings, the increase in respiration because of FFA was about double that in mitochondria from controls. There was no change in creatine kinase activity from liver and I mitochondria, but a 16% decrease in this enzyme activity (expressed per mg mitochondrial protein) from S mitochondria was shown despite a strong increase in cytochrome oxidase activity from liver mitochondria (+114% if expressed per g tissue) and from muscle mitochondria (I, +53 or +48%; S, +41 or +97% if expressed per mg mitochondrial protein or per g tissue, respectively). These results support a coupling defect in liver and skeletal muscle mitochondria from the GT hyperthermic ducklings and an uncoupling reinforcement by FFA.
Barré
H
H
Laboratoire de Thermorégulation et Métabolisme Energétique, Faculté de Médecine Lyon-Nord, France.
Berne
G
G
Brebion
P
P
Cohen-Adad
F
F
Rouanet
J L
JL
D000818:Animals; D001833:Body Temperature Regulation / Q000187:drug effects*; D003402:Creatine Kinase / Q000378:metabolism; D004372:Ducks; D003576:Electron Transport Complex IV / Q000378:metabolism; D005934:Glucagon / Q000494:pharmacology*; D008930:Mitochondria, Liver / Q000187:drug effects / Q000378:metabolism*; D008931:Mitochondria, Muscle / Q000187:drug effects / Q000378:metabolism* / Q000648:ultrastructure; D009132:Muscles / Q000502:physiology; D009928:Organ Specificity; D010101:Oxygen Consumption / Q000187:drug effects; D012016:Reference Values; D012508:Sarcolemma / Q000378:metabolism
D005934:Glucagon; D003576:Electron Transport Complex IV; D003402:Creatine Kinase